MENU
LUMO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lumos Pharma (LUMO) Ownership - Who owns Lumos Pharma?
Profile
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 512 215-2630
Employees
33
Web
https://www.lumos-pharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
32.01M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
518K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.18 USD as % of share price
Fundamentals
LUMO
Capitalization
32M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
518K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.18%
Revenue
N/A
ROE
N/A
Book Value
17.4M
P/B Ratio
3.12
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
81K
Current Ratio
6.24
Current Revenue Per Employee
5000.00
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
8.12M
Total Liabilities
10.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
23.585
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which engages in the development of therapeutics for the treatment of Pediatric Growth Hormone Deficiency (PGHD)
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 512 215-2630
Employees
33
Web
https://www.lumos-pharma.com